Clinical Trials on Retinal Ischemia in New Zealand

Total 2819 results

University of California, San Diego
University of Minnesota; Rady Children's Hospital, San Diego; Middlemore Hospital... and other collaborators

Recruiting

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures (NEOLEV3)

Hypoxic-Ischemic Encephalopathy | Neonatal Encephalopathy | Neonatal Seizure | Seizure Newborn

United States, New Zealand
Pfenex, Inc

Completed

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Age Related Macular Degeneration (AMD)

New Zealand
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
University of Sydney
National Health and Medical Research Council, Australia

Active, not recruiting

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns (PAEAN)

Hypoxic-Ischemic Encephalopathy

Australia, Singapore, New Zealand
Neuroscience Trials Australia
National Health and Medical Research Council, Australia; Monash University

Active, not recruiting

Trial of EXenatide in Acute Ischaemic Stroke (TEXAIS)

Acute Ischemic Stroke

Australia, Finland, New Zealand
Hoffmann-La Roche

Completed

A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)

End Stage Renal Disease

New Zealand
Route 92 Medical, Inc.

Completed

Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMITNZ)

Acute Ischemic Stroke

New Zealand
Academy of Nutrition and Dietetics

Completed

Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?

End Stage Renal Disease Requiring Hemodialysis

New Zealand
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Auckland District Health Board
Novartis; University of Auckland, New Zealand; IGENZ, Ltd., Auckland

Unknown

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC (DILIGENCE-1)

Clear Cell Renal Cell Carcinoma

New Zealand
The Medicines Company

Completed

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

Renal Impairment

New Zealand
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
Dart NeuroScience, LLC

Terminated

DNS-3379 vs. Placebo in Stroke Rehabilitation (SPIRIT)

Ischemic Stroke

Australia, New Zealand
Olympic Medical

Completed

CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy

Neonatal Hypoxic-Ischemic Encephalopathy (HIE)

United States, Canada, United Kingdom, New Zealand
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Gilead Sciences

Completed

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

HIV

United States, New Zealand
Spero Therapeutics
United States Department of Defense

Completed

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Renal Impairment

New Zealand
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)

Ischemic Stroke

Australia, New Zealand
University Hospitals Cleveland Medical Center
The University of Texas Health Science Center, Houston; Stryker Neurovascular

Completed

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT2)

Acute Ischemic Stroke

Spain, United States, Canada, Australia, New Zealand, Switzerland
AstraZeneca

Completed

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] (SOCRATES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Sweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
University of Cologne

Completed

Analysis of Remote-ischemic Preconditioning Effects on Kidney Function (RenPRO-TAVI)

Renal Function | Renal Injury

Germany
AstraZeneca

Completed

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death (THALES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Belgium, France, Italy, Spain, Sweden, Thailand, Germany, Korea, Republic of, Brazil, Hungary, India, Mexico, Vietnam, China, Taiwan, Hong Kong, Slovakia, Australia, Poland, Saudi Arabia, Ukraine, Canada, Russian Federation, Bulgaria, R... and more
ONL Therapeutics

Completed

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Geographic Atrophy

New Zealand, Australia
Gilead Sciences

Completed

Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant

Chronic Hepatitis B

New Zealand
Elixir Medical Corporation

Completed

DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

Coronary Artery Disease

New Zealand
New York Medical College
Celgene

Withdrawn

Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy (HPDSC+HIE)

Severe Hypoxic-ischemic Encephalopathy

United States
Auckland City Hospital

Recruiting

MAnagement of Systolic Blood Pressure During Thrombectomy by Endovascular Route for Acute Ischaemic STROKE (MASTERSTROKE)

Stroke | Blood Pressure | Embolus Cerebral

New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
University of Massachusetts, Worcester
Yale University

Withdrawn

Decision Aid Feasibility Trial for Families of Critically Ill Stroke Patients

Ischemic Stroke | Hemorrhagic Stroke | Intracerebral Hemorrhage | Ischaemic Stroke With Coma

United States
Millard Fillmore Gates Hospital
Kaleida Health

Unknown

Lovaza's Effect on Clopidogrel in a Neuro Population

Ischemic Stroke | Transient Ischemic Attack

United States
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)

Ischemic Stroke

Australia, New Zealand
Cagent Vascular LLC

Completed

The PRELUDE BTK Study

Peripheral Arterial Disease | Critical Limb Ischemia

New Zealand, Austria, Germany, Poland
National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
Columbia University

Active, not recruiting

Sildenafil for Treatment of Choroidal Ischemia

Age-related Macular Degeneration | Retinitis Pigmentosa | Vitelliform Macular Dystrophy | Choroidal Ischemia | Central Serous Retinopathy

United States
Narrows Institute for Biomedical Research

Completed

The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial (PREVENTS)

Stroke | Transient Ischemic Attack

United States
Micell Technologies

Completed

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)

Coronary Artery Disease

Belgium, Australia, New Zealand
Albany Medical College
Medtronic

Terminated

The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy

HIE - Perinatal Hypoxic - Ischemic Encephalopathy

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

Macular Edema

Australia, United States, New Zealand
Meridigen Biotech Co., Ltd.

Recruiting

Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke

Taiwan
The University of Texas Health Science Center,...

Terminated

Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging (PETREVASC)

Ischemic Heart Disease

United States
Silk Road Medical

Recruiting

Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System (NITE1)

Acute Ischemic Stroke

United States
NYU Langone Health

Terminated

Stress Reduction Intervention for Women With Ischemic Heart Disease

Ischemic Heart Disease

United States
NYU Langone Health
Astellas Pharma Inc

Completed

Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests (DASI-08-713)

Ischemic Heart Disease

United States
AbbVie

Completed

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

Renal Impairment

United States, New Zealand
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease

Ischemic Heart Disease

United States
LCMC Health

Recruiting

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

Acute Ischemic Stroke

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
MedImmune LLC

Completed

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects

Renal Insufficiency

New Zealand, Germany
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands

Clinical Trials on Retinal Ischemia in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations